Publications by authors named "J A Gaken"

Head and neck squamous cell carcinomas (HNSCC) are associated with poor morbidity and mortality. Current treatment strategies are highly toxic and do not benefit over 50% of patients. There is therefore a crucial need for predictive and/or prognostic biomarkers to allow treatment stratification for individual patients.

View Article and Find Full Text PDF

MicroRNAs are short endogenous noncoding RNAs that play pivotal roles in a diverse range of cellular processes. The miR-181 family is important in T cell development, proliferation, and activation. In this study, we have identified BRK1 as a potential target of miR-181c using a dual selection functional assay and have showed that miR-181c regulates BRK1 by translational inhibition.

View Article and Find Full Text PDF

The E3 ubiquitin ligase RNF168 is a ring finger protein that has previously been identified to play an important regulatory role in the repair of double-strand DNA breaks.  In the present study, an unbiased forward genetics functional screen in mouse granulocyte/ macrophage progenitor cell line FDCP1 has identified E3 ubiquitin ligase RNF168 as a key regulator of cell survival and proliferation. Our data indicate that RNF168 is an important component of the mechanisms controlling cell fate, not only in human and mouse haematopoietic growth factor-dependent cells, but also in the human breast epithelial cell line MCF-7.

View Article and Find Full Text PDF

We investigated the functional consequences following deletion of a microRNA (miR) termed miR-595 which resides on chromosome 7q and is localised within one of the commonly deleted regions identified for Myelodysplasia (MDS) with monosomy 7 (-7)/isolated loss of 7q (7q-). We identified several targets for miR-595, including a large ribosomal subunit protein RPL27A. RPL27A downregulation induced p53 activation, apoptosis and inhibited proliferation.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate the frequency and clinical significance of CSNK1A1 mutations in patients with myelodysplastic syndrome and associated myeloid neoplasms, focusing on those with isolated del(5q) abnormalities.
  • Out of 250 patients with myeloid neoplasms, 39 had isolated del(5q), and 7 of these (18%) carried missense mutations in CSNK1A1, a gene involved in bone marrow proliferation and ATP catalysis.
  • The presence of CSNK1A1 mutations correlated with poor treatment response and disease progression in patients, similar to TP53 mutations, indicating they contribute to a worse prognosis in del(5q) abnormalities.
View Article and Find Full Text PDF